{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:21:31Z","timestamp":1773937291129,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100011022","name":"Vertex Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011022","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40801-025-00531-9","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:23:29Z","timestamp":1763630609000},"page":"29-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Health Equity Concerns in People with Sickle Cell Disease and Recurrent Vaso-Occlusive Crises: Results from an International Survey Study"],"prefix":"10.1007","volume":"13","author":[{"given":"Adriana","family":"Boateng-Kuffour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Lilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Drahos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Valentine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Pakbaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farrukh","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Ainsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antony P.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"531_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.36469\/9667","volume":"6","author":"N Shah","year":"2019","unstructured":"Shah N, Bhor M, Xie L, Halloway R, Arcona S, Paulose J, et al. Evaluation of vaso-occlusive crises in United States sickle cell disease patients: a retrospective claims-based study. J Health Econ Outcomes Res. 2019;6:106\u201317. https:\/\/doi.org\/10.36469\/9667.","journal-title":"J Health Econ Outcomes Res"},{"key":"531_CR2","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMra1510865","volume":"376","author":"FB Piel","year":"2017","unstructured":"Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017;376:1561\u201373. https:\/\/doi.org\/10.1056\/NEJMra1510865.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"531_CR3","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1097\/j.pain.0000000000000824","volume":"158","author":"AM Brandow","year":"2017","unstructured":"Brandow AM, Zappia KJ, Stucky CL. Sickle cell disease: a natural model of acute and chronic pain. Pain. 2017;158(Suppl 1):S79-s84. https:\/\/doi.org\/10.1097\/j.pain.0000000000000824.","journal-title":"Pain"},{"key":"531_CR4","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1182\/blood-2023-189699","volume":"142","author":"J Drahos","year":"2023","unstructured":"Drahos J, Boateng-Kuffour A, Calvert M, Valentine A, Mason A, Li N, et al. The impact of recent vaso-occlusive crisis on health-related quality of life in adults with sickle cell disease. Blood. 2023;142:3678\u20133678. https:\/\/doi.org\/10.1182\/blood-2023-189699.","journal-title":"Blood"},{"issue":"7","key":"531_CR5","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s11136-025-03963-6","volume":"34","author":"J Drahos","year":"2025","unstructured":"Drahos J, Boateng-Kuffour A, Calvert M, Valentine A, Mason A, Li N, et al. Health-related quality of life and economic impacts in adults with sickle cell disease with recurrent vaso-occlusive crises: findings from a prospective longitudinal real-world survey. Qual Life Res. 2025;34(7):2019\u201329. https:\/\/doi.org\/10.1007\/s11136-025-03963-6.","journal-title":"Qual Life Res"},{"key":"531_CR6","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC202101190","volume":"174","author":"LH Pecker","year":"2021","unstructured":"Pecker LH, Lanzkron S. Sickle Cell Disease. Ann Intern Med. 2021;174:ITC1\u201316. https:\/\/doi.org\/10.7326\/AITC202101190.","journal-title":"Ann Intern Med"},{"key":"531_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ajem.2012.11.005","volume":"31","author":"C Haywood Jr","year":"2013","unstructured":"Haywood C Jr, Tanabe P, Naik R, Beach MC, Lanzkron S. The impact of race and disease on sickle cell patient wait times in the emergency department. Am J Emerg Med. 2013;31:651\u20136. https:\/\/doi.org\/10.1016\/j.ajem.2012.11.005.","journal-title":"Am J Emerg Med"},{"key":"531_CR8","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/13557858.2020.1817340","volume":"27","author":"AM Hood","year":"2022","unstructured":"Hood AM, Crosby LE, Hanson E, Shook LM, Lebensburger JD, Madan-Swain A, et al. The influence of perceived racial bias and health-related stigma on quality of life among children with sickle cell disease. Ethn Health. 2022;27:833\u201346. https:\/\/doi.org\/10.1080\/13557858.2020.1817340.","journal-title":"Ethn Health"},{"issue":"5","key":"531_CR9","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jpainsymman.2014.02.002","volume":"48","author":"C Haywood Jr.","year":"2014","unstructured":"Haywood C Jr., Diener-West M, Strouse J, Carroll CP, Bediako S, Lanzkron S, et al. Perceived discrimination in health care is associated with a greater burden of pain in sickle cell disease. J Pain Symptom Manage. 2014;48(5):934\u201343. https:\/\/doi.org\/10.1016\/j.jpainsymman.2014.02.002.","journal-title":"J Pain Symptom Manage"},{"key":"531_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1177\/0033354919881438","volume":"134","author":"L Lee","year":"2019","unstructured":"Lee L, Smith-Whitley K, Banks S, Puckrein G. Reducing health care disparities in sickle cell disease: a review. Public Health Rep. 2019;134:599\u2013607. https:\/\/doi.org\/10.1177\/0033354919881438.","journal-title":"Public Health Rep"},{"key":"531_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/01612840.2018.1443530","volume":"39","author":"D Bulgin","year":"2018","unstructured":"Bulgin D, Tanabe P, Jenerette C. Stigma of sickle cell disease: a systematic review. Issues Ment Health Nurs. 2018;39:675\u201386. https:\/\/doi.org\/10.1080\/01612840.2018.1443530.","journal-title":"Issues Ment Health Nurs"},{"key":"531_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-050880","volume":"11","author":"MP Smeltzer","year":"2021","unstructured":"Smeltzer MP, Howell KE, Treadwell M, Preiss L, King AA, Glassberg JA, et al. Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA. BMJ Open. 2021;11:e050880. https:\/\/doi.org\/10.1136\/bmjopen-2021-050880.","journal-title":"BMJ Open"},{"key":"531_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pain.2010.04.025","volume":"150","author":"D Amtmann","year":"2010","unstructured":"Amtmann D, Cook KF, Jensen MP, Chen WH, Choi S, Revicki D, et al. Development of a PROMIS item bank to measure pain interference. Pain. 2010;150:173\u201382. https:\/\/doi.org\/10.1016\/j.pain.2010.04.025.","journal-title":"Pain"},{"key":"531_CR14","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.mlr.0000258615.42478.55","volume":"45","author":"D Cella","year":"2007","unstructured":"Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care. 2007;45:S3\u201311. https:\/\/doi.org\/10.1097\/01.mlr.0000258615.42478.55.","journal-title":"Med Care"},{"key":"531_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12955-014-0125-0","volume":"12","author":"SD Keller","year":"2014","unstructured":"Keller SD, Yang M, Treadwell MJ, Werner EM, Hassell KL. Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banks. Health Qual Life Outcomes. 2014;12:125. https:\/\/doi.org\/10.1186\/s12955-014-0125-0.","journal-title":"Health Qual Life Outcomes"},{"key":"531_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004528","volume":"95","author":"CT Evensen","year":"2016","unstructured":"Evensen CT, Treadwell MJ, Keller S, Levine R, Hassell KL, Werner EM, et al. Quality of care in sickle cell disease: cross-sectional study and development of a measure for adults reporting on ambulatory and emergency department care. Medicine (Baltimore). 2016;95:e4528. https:\/\/doi.org\/10.1097\/MD.0000000000004528.","journal-title":"Medicine (Baltimore)"},{"key":"531_CR17","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1097\/00006842-200109000-00020","volume":"63","author":"R Edwards","year":"2001","unstructured":"Edwards R, Telfair J, Cecil H, Lenoci J. Self-efficacy as a predictor of adult adjustment to sickle cell disease: one-year outcomes. Psychosom Med. 2001;63:850\u20138. https:\/\/doi.org\/10.1097\/00006842-200109000-00020.","journal-title":"Psychosom Med"},{"key":"531_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/09297040600770746","volume":"13","author":"OJ Clay","year":"2007","unstructured":"Clay OJ, Telfair J. Evaluation of a disease-specific self-efficacy instrument in adolescents with sickle cell disease and its relationship to adjustment. Child Neuropsychol. 2007;13:188\u2013203. https:\/\/doi.org\/10.1080\/09297040600770746.","journal-title":"Child Neuropsychol"},{"key":"531_CR19","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/s0005-7967(99)00140-0","volume":"38","author":"R Edwards","year":"2000","unstructured":"Edwards R, Telfair J, Cecil H, Lenoci J. Reliability and validity of a self-efficacy instrument specific to sickle cell disease. Behav Res Ther. 2000;38:951\u201363. https:\/\/doi.org\/10.1016\/s0005-7967(99)00140-0.","journal-title":"Behav Res Ther"},{"key":"531_CR20","unstructured":"Tables of Descriptive Statistics in HTML [https:\/\/CRAN.R-project.org\/package=table1]"},{"key":"531_CR21","unstructured":"R: a language and environment for statistical ## computing. https:\/\/www.r-project.org\/."},{"key":"531_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jama.2007.64","volume":"299","author":"MJ Pletcher","year":"2008","unstructured":"Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R. Trends in opioid prescribing by race\/ethnicity for patients seeking care in US emergency departments. JAMA. 2008;299:70\u20138. https:\/\/doi.org\/10.1001\/jama.2007.64.","journal-title":"JAMA"},{"key":"531_CR23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1056\/NEJMsa2034159","volume":"385","author":"NE Morden","year":"2021","unstructured":"Morden NE, Chyn D, Wood A, Meara E. Racial inequality in prescription opioid receipt\u2014role of individual health systems. N Engl J Med. 2021;385:342\u201351. https:\/\/doi.org\/10.1056\/NEJMsa2034159.","journal-title":"N Engl J Med"},{"key":"531_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13122-y","volume":"22","author":"S Hamed","year":"2022","unstructured":"Hamed S, Bradby H, Ahlberg BM, Thapar-Bj\u00f6rkert S. Racism in healthcare: a scoping review. BMC Public Health. 2022;22:988. https:\/\/doi.org\/10.1186\/s12889-022-13122-y.","journal-title":"BMC Public Health"},{"key":"531_CR25","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1056\/NEJMp2022125","volume":"383","author":"A Power-Hays","year":"2020","unstructured":"Power-Hays A, McGann PT. When actions speak louder than words\u2014racism and sickle cell disease. N Engl J Med. 2020;383:1902\u20133. https:\/\/doi.org\/10.1056\/NEJMp2022125.","journal-title":"N Engl J Med"},{"key":"531_CR26","doi-asserted-by":"publisher","first-page":"E53","DOI":"10.1097\/NCC.0000000000000750","volume":"44","author":"BW Dyal","year":"2021","unstructured":"Dyal BW, Abudawood K, Schoppee TM, Jean S, Smith VM, Greenlee A, et al. Reflections of healthcare experiences of African Americans with sickle cell disease or cancer: a qualitative study. Cancer Nurs. 2021;44:E53-e61. https:\/\/doi.org\/10.1097\/NCC.0000000000000750.","journal-title":"Cancer Nurs"},{"key":"531_CR27","doi-asserted-by":"publisher","DOI":"10.1037\/sah0000581","author":"LS McGill","year":"2024","unstructured":"McGill LS, S\u00e1nchez Gonz\u00e1lez ML, Bediako SM, Lanzkron SM, Yu L, Beach MC, et al. Impact of disease- and race-based discrimination in health care on pain outcomes among adults living with sickle cell disease in the United States: the mediating roles of internalized stigma and depressive symptoms. Stigma Health. 2024. https:\/\/doi.org\/10.1037\/sah0000581.","journal-title":"Stigma Health"},{"key":"531_CR28","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1007\/s11136-024-03805-x","volume":"33","author":"JK Wu","year":"2024","unstructured":"Wu JK, McVay K, Mahoney KM, Sayani FA, Roe AH, Cebert M. Experiences with healthcare navigation and bias among adult women with sickle cell disease: a qualitative study. Qual Life Res. 2024;33:3459\u201367. https:\/\/doi.org\/10.1007\/s11136-024-03805-x.","journal-title":"Qual Life Res"},{"key":"531_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/AJP.0000000000000827","volume":"36","author":"S Sil","year":"2020","unstructured":"Sil S, Cohen LL, Bakshi N, Watt A, Hathaway M, Abudulai F, et al. Changes in pain and psychosocial functioning and transition to chronic pain in pediatric sickle cell disease: a cohort follow-up study. Clin J Pain. 2020;36:463\u201371. https:\/\/doi.org\/10.1097\/AJP.0000000000000827.","journal-title":"Clin J Pain"},{"key":"531_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/07347332.2022.2046676","volume":"41","author":"HM Fisher","year":"2023","unstructured":"Fisher HM, Stalls J, Winger JG, Miller SN, Plumb Vilardaga JC, Majestic C, et al. Role of self-efficacy for pain management and pain catastrophizing in the relationship between pain severity and depressive symptoms in women with breast cancer and pain. J Psychosoc Oncol. 2023;41:87\u2013103. https:\/\/doi.org\/10.1080\/07347332.2022.2046676.","journal-title":"J Psychosoc Oncol"},{"key":"531_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/AJP.0000000000000094","volume":"31","author":"JR Skidmore","year":"2015","unstructured":"Skidmore JR, Koenig AL, Dyson SJ, Kupper AE, Garner MJ, Keller CJ. Pain self-efficacy mediates the relationship between depressive symptoms and pain severity. Clin J Pain. 2015;31:137\u201344. https:\/\/doi.org\/10.1097\/AJP.0000000000000094.","journal-title":"Clin J Pain"},{"key":"531_CR32","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","volume":"4","author":"AM Brandow","year":"2020","unstructured":"Brandow AM, Carroll CP, Creary S, Edwards-Elliott R, Glassberg J, Hurley RW, et al. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Adv. 2020;4:2656\u2013701. https:\/\/doi.org\/10.1182\/bloodadvances.2020001851.","journal-title":"Blood Adv"},{"key":"531_CR33","unstructured":"(NICE) NIfHaCE: Surveillance report 2016\u2014Sickle cell disease: managing acute painful episodes in hospital (2012) NICE guideline CG143. London: National Institute for Health and Care Excellence (NICE) Copyright \u00a9 NICE 2016; 2016."},{"key":"531_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2012.11.005","volume":"118","author":"C Haywood Jr.","year":"2011","unstructured":"Haywood C Jr., Naik R, Beach MC, Lanzkron S. Do sickle cell patients wait longer to see physicians in the emergency department? Blood. 2011;118:2070-2070. https:\/\/doi.org\/10.1016\/j.ajem.2012.11.005.","journal-title":"Blood"},{"key":"531_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12912-019-0380-9","volume":"18","author":"DT Kahsay","year":"2019","unstructured":"Kahsay DT, Pitk\u00e4j\u00e4rvi M. Emergency nurses\u00b4 knowledge, attitude and perceived barriers regarding pain management in resource-limited settings: cross-sectional study. BMC Nurs. 2019;18:56. https:\/\/doi.org\/10.1186\/s12912-019-0380-9.","journal-title":"BMC Nurs"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-025-00531-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40801-025-00531-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-025-00531-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:40:11Z","timestamp":1773931211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40801-025-00531-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["531"],"URL":"https:\/\/doi.org\/10.1007\/s40801-025-00531-9","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"10 November 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Adriana Boateng-Kuffour, Lauren Lilly, Jennifer Drahos, and Nanxin Li are employees of Vertex Pharmaceuticals Incorporated and may hold stock or stock options in the company. Melanie Calvert is Director of the Centre for Patient-Reported Outcomes Research and Deputy Director Birmingham Health Partners Centre for Regulatory Science and Innovation and a National Institute for Health and Care Research (NIHR) senior investigator; has received funding from Anthony Nolan, European Regional Development Fund, Gilead, GSK, LifeArc, Merck, MHRA, NIHR, NIHR ARC WM, NIHR Birmingham BRC, NIHR BTRU Precision and Cellular Therapeutics, UKRI; and has received consultancy fees from Aparito, Beta6, Boehringer Ingelheim, CIS Oncology, Gilead, Halfloop, ICON, Merck, Northwestern University, Pfizer, Shionogi and Vertex Pharmaceuticals Incorporated. Ashley Valentine has received consulting fees for Atlas Clarity Consulting Firm and Vertex Pharmaceuticals Incorporated; acted as Board of Director for IVI; and acted as an advisory board member for PCORI. Anthony Mason has received consulting fees for Vertex Pharmaceuticals Incorporated. Zahra Pakbaz has received research grants from Amgen, Forma Therapeutics, Global Blood Therapeutics, Novartis, Novo Nordisk, and Pfizer; received consulting fees from Agio, Alexion, Amgen, Global Blood Therapeutics, Novartis, Sobi, and Vertex Pharmaceuticals Incorporated; received speaker fees from SOBI, Agio, GPT, Aplastic Anemia MDS foundation, Cayenne Wellness Center and Child Foundation, and acted as a CME course director for the Cayenne Wellness Center and Child Foundation and planning committee member for their annual education symposium. Farrukh Shah has received research grants from IQVIA, Novartis Pharma AG, Pharmacosmos, and Vertex Pharmaceuticals Incorporated; received honoraria from Biologix FZ co, Bristol Myers Squibb, Chiesi Ltd, and Novartis Pharma AG; served as an advisory board or committee member for Agios, bluebird bio, Bristol Myers Squibb, Silence Therapeutics Plc, and Vertex Pharmaceuticals Incorporated; and acted as Chair for the UK Forum on Haemoglobin Disorders. Nick Ainsworth is an employee of QC Medica and Antony P. Martin is a partner of QC Medica which was funded by Vertex Pharmaceuticals Incorporated to perform this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Raw data is not publicly available in order to protect participant privacy. Requests for data can be made to the corresponding author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Materials"}},{"value":"All authors contributed to the study conception and design. Material preparations were performed by all authors. Data collections were performed by Antony P. Martin and Nick Ainsworth. Analyses were performed by Adriana Boateng-Kuffour, Lauren Lilly, Jennifer Drahos, Melanie Calvert, Nanxin Li, Nick Ainsworth, and Antony P. Martin. All authors critically reviewed, contributed to, and approved the final manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions and Guarantor Statement"}},{"value":"Ethical approval was not required for this study and exemption for this study was granted by WIRB-Copernicus Group Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All analyses were performed using R (version 4.3.1) and R Studio (version 2023.06.1+524) software. No custom code was developed for this study.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}